243 related articles for article (PubMed ID: 24336827)
1. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.
Litvintseva AP; Lindsley MD; Gade L; Smith R; Chiller T; Lyons JL; Thakur KT; Zhang SX; Grgurich DE; Kerkering TM; Brandt ME; Park BJ
Clin Infect Dis; 2014 Mar; 58(5):622-30. PubMed ID: 24336827
[TBL] [Abstract][Full Text] [Related]
2. (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections.
Malani AN; Singal B; Wheat LJ; Al Sous O; Summons TA; Durkin MM; Pettit AC
J Clin Microbiol; 2015 Mar; 53(3):799-803. PubMed ID: 25540391
[TBL] [Abstract][Full Text] [Related]
3. Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis.
Myint T; Chow FC; Bloch KC; Raymond-Guillen L; Davis TE; Wright PW; Woc-Colburn L; Khairy RN; Street AC; Yamamoto T; Albers A; Wheat LJ; Hage CA
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30021828
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid (1,3)-β-D-glucan in isolated Candida meningitis.
Lyons JL; Erkkinen MG; Vodopivec I
Clin Infect Dis; 2015 Jan; 60(1):161-2. PubMed ID: 25228700
[No Abstract] [Full Text] [Related]
5. Utility of real-time PCR for detection of Exserohilum rostratum in body and tissue fluids during the multistate outbreak of fungal meningitis and other infections.
Gade L; Grgurich DE; Kerkering TM; Brandt ME; Litvintseva AP
J Clin Microbiol; 2015 Feb; 53(2):618-25. PubMed ID: 25520443
[TBL] [Abstract][Full Text] [Related]
6. Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis.
Rhein J; Bahr NC; Morawski BM; Schutz C; Zhang Y; Finkelman M; Meya DB; Meintjes G; Boulware DR
Open Forum Infect Dis; 2014 Dec; 1(3):ofu105. PubMed ID: 25734173
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis.
Lyons JL; Roos KL; Marr KA; Neumann H; Trivedi JB; Kimbrough DJ; Steiner L; Thakur KT; Harrison DM; Zhang SX
J Clin Microbiol; 2013 Apr; 51(4):1285-7. PubMed ID: 23363831
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Cerebrospinal Fluid Beta-d-Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review.
Davis C; Wheat LJ; Myint T; Boulware DR; Bahr NC
J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31996446
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
10. (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.
Salvatore CM; Chen TK; Toussi SS; DeLaMora P; Petraitiene R; Finkelman MA; Walsh TJ
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):277-86. PubMed ID: 26407252
[TBL] [Abstract][Full Text] [Related]
11. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.
Stevens DA; Zhang Y; Finkelman MA; Pappagianis D; Clemons KV; Martinez M
J Clin Microbiol; 2016 Nov; 54(11):2707-2710. PubMed ID: 27558179
[TBL] [Abstract][Full Text] [Related]
13. UTILITY OF OCULAR β- d -GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.
Xia T; Finkelman M; Kolomeyer A; Ying GS; Bracha P; Miller CG; Elnahry AG; Carroll R; Zhang Y; Saluadades A; Brucker AJ; Kim BJ
Retin Cases Brief Rep; 2023 Nov; 17(6):676-682. PubMed ID: 35199648
[TBL] [Abstract][Full Text] [Related]
14. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
[TBL] [Abstract][Full Text] [Related]
15. Challenging diagnosis of chronic cerebral fungal infection: Value of (1→3)-ß-D-glucan and mannan antigen testing in cerebrospinal fluid and of cerebral ventricle puncture.
Hobson CA; Desoubeaux G; Carvalho-Schneider C; Destrieux C; Cottier JP; Garot D; Le Brun C; Maakaroun Z; Lemaignen A; Bailly É; Bernard L
Med Mycol; 2021 Jan; 59(1):74-80. PubMed ID: 32470986
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia.
Dichtl K; Seybold U; Wagener J
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29720434
[TBL] [Abstract][Full Text] [Related]
17. BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.
Kolomeyer AM; Murphy KM; Traband A; Frank I; Kim BJ
Retina; 2018 Apr; 38(4):650-659. PubMed ID: 29370030
[TBL] [Abstract][Full Text] [Related]
18. Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β-d-Glucan Assay.
Skubic J; Taghavi S; Castillo-Angeles M; Ramsis R; Salim A; Askari R
Surg Infect (Larchmt); 2020 Jun; 21(5):461-464. PubMed ID: 31895667
[No Abstract] [Full Text] [Related]
19. Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection.
Lyons JL; Thakur KT; Lee R; Watkins T; Pardo CA; Carson KA; Markley B; Finkelman MA; Marr KA; Roos KL; Zhang SX
J Clin Microbiol; 2015 Jan; 53(1):319-22. PubMed ID: 25378578
[TBL] [Abstract][Full Text] [Related]
20. Plasma (1 → 3)-β-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis.
Gianella S; Letendre SL; Iudicello J; Franklin D; Gaufin T; Zhang Y; Porrachia M; Vargas-Meneses M; Ellis RJ; Finkelman M; Hoenigl M
J Neurovirol; 2019 Dec; 25(6):837-843. PubMed ID: 31297727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
